{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:11Z","timestamp":1777564571442,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"DOI":"10.1186\/s12938-025-01418-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:38:19Z","timestamp":1752136699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical value of serum uric acid and homocysteine levels in predicting the occurrence of atrial fibrillation in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"24","author":[{"given":"Dong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"15","key":"1418_CR1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","volume":"141","author":"TA Zelniker","year":"2020","unstructured":"Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, et al. Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation. 2020;141(15):1227\u201334.","journal-title":"Circulation"},{"issue":"4","key":"1418_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","volume":"16","author":"P Farmaki","year":"2020","unstructured":"Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the type 2 diabetes mellitus. Curr Cardiol Rev. 2020;16(4):249\u201351.","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"1418_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacc.2021.04.079","volume":"78","author":"G Filippatos","year":"2021","unstructured":"Filippatos G, Bakris GL, Pitt B, Agarwal R, Rossing P, Ruilope LM, Butler J, Lam CSP, Kolkhof P, Roberts L, et al. Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes. J Am Coll Cardiol. 2021;78(2):142\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1418_CR4","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","volume":"79","author":"C Borghi","year":"2022","unstructured":"Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric Acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022;79(9):1927\u201336.","journal-title":"Hypertension"},{"issue":"9","key":"1418_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022138","volume":"11","author":"KW Nam","year":"2022","unstructured":"Nam KW, Kim CK, Yu S, Oh K, Chung JW, Bang OY, Kim GM, Jung JM, Song TJ, Kim YJ, et al. Plasma total homocysteine level is related to unfavorable outcomes in ischemic stroke with atrial fibrillation. J Am Heart Assoc. 2022;11(9): e022138.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1418_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.numecd.2020.10.012","volume":"31","author":"X Sun","year":"2021","unstructured":"Sun X, Lu Y, Wang Z, Wang Q, Zheng L. No causal association between plasma homocysteine levels and atrial fibrillation: a Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2021;31(2):587\u201391.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"1418_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/ejhf.1646","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer M. Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment. Eur J Heart Fail. 2020;22(2):214\u201327.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"1418_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-019-0983-1","volume":"19","author":"S Seyed Ahmadi","year":"2020","unstructured":"Seyed Ahmadi S, Svensson AM, Pivodic A, Rosengren A, Lind M. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1418_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/10547738211046441","volume":"31","author":"E Karaman","year":"2022","unstructured":"Karaman E, Kalk\u0131m A, \u015earer Y\u00fcrekli BP. Determining the cardiovascular disease risk factor knowledge and related factors among adults with type 2 diabetes mellitus. Clin Nurs Res. 2022;31(4):579\u201387.","journal-title":"Clin Nurs Res"},{"issue":"1","key":"1418_CR10","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1038\/s41598-021-84307-5","volume":"11","author":"CS Park","year":"2021","unstructured":"Park CS, Han KD, Choi EK, Kim DH, Lee HJ, Lee SR, Oh S. Lifestyle is associated with atrial fibrillation development in patients with type 2 diabetes mellitus. Sci Rep. 2021;11(1):4676.","journal-title":"Sci Rep"},{"issue":"5","key":"1418_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/joim.13688","volume":"294","author":"C Johansson","year":"2023","unstructured":"Johansson C, \u00d6rtendahl L, Lind MM, Andersson J, Johansson L, Brunstr\u00f6m M. Diabetes, prediabetes, and atrial fibrillation-a population-based cohort study based on national and regional registers. J Intern Med. 2023;294(5):605\u201315.","journal-title":"J Intern Med"},{"issue":"10","key":"1418_CR12","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.numecd.2021.05.034","volume":"31","author":"X Wang","year":"2021","unstructured":"Wang X, Hou Y, Wang X, Li Z, Wang X, Li H, Shang L, Zhou J, Zhang Y, Ren M, et al. Relationship between serum uric acid levels and different types of atrial fibrillation: an updated meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(10):2756\u201365.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"1418_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/met.2020.0142","volume":"19","author":"Q Wang","year":"2021","unstructured":"Wang Q, Fu C, Xia H, Gao Y. Elevated plasma homocysteine level associated with further left ventricular structure and function damages in type 2 diabetic patients: a three-dimensional speckle tracking echocardiography study. Metab Syndr Relat Disord. 2021;19(8):443\u201351.","journal-title":"Metab Syndr Relat Disord"},{"issue":"10","key":"1418_CR14","doi-asserted-by":"publisher","first-page":"e0276087","DOI":"10.1371\/journal.pone.0276087","volume":"17","author":"NN Rabelo","year":"2022","unstructured":"Rabelo NN, Telles JPM, Pipek LZ, Farias Vidigal Nascimento R, Gusm\u00e3o RC, Teixeira MJ, Figueiredo EG. Homocysteine is associated with higher risks of ischemic stroke: a systematic review and meta-analysis. PLoS ONE. 2022;17(10):e0276087.","journal-title":"PLoS ONE"},{"key":"1418_CR15","doi-asserted-by":"publisher","first-page":"1109445","DOI":"10.3389\/fcvm.2022.1109445","volume":"9","author":"D Yuan","year":"2022","unstructured":"Yuan D, Chu J, Lin H, Zhu G, Qian J, Yu Y, Yao T, Ping F, Chen F, Liu X. Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis. Front Cardiovasc Med. 2022;9:1109445.","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"1418_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14715\/cmb\/2023.69.15.13","volume":"69","author":"M Peng","year":"2023","unstructured":"Peng M, Wu Y, Jin Y. Correlations of GGT, Hcy and ABI with carotid atherosclerosis in essential hypertension patients. Cell Mol Biol (Noisy-le-Grand, France). 2023;69(15):79\u201383.","journal-title":"Cell Mol Biol (Noisy-le-Grand, France)"},{"issue":"4","key":"1418_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/labmed\/lmz003","volume":"50","author":"K Okada","year":"2019","unstructured":"Okada K, Okabe M, Kimura Y, Itoh H, Ikemoto M. Serum S100A8\/A9 as a potentially sensitive biomarker for inflammatory bowel disease. Lab Med. 2019;50(4):370\u201380.","journal-title":"Lab Med"},{"issue":"7","key":"1418_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2174\/1568009622666220523154333","volume":"23","author":"S Wu","year":"2023","unstructured":"Wu S, Zhang J, Wei H, Liu Y, Dai X, Xue J, Shen T, Liu X. Serum biomarker panel for rapid early diagnosis of lung cancer. Curr Cancer Drug Targets. 2023;23(7):534\u201346.","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"1418_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027089","volume":"12","author":"M Ding","year":"2023","unstructured":"Ding M, Viet NN, Gigante B, Lind V, Hammar N, Modig K. Elevated uric acid is associated with new-onset atrial fibrillation: results from the Swedish AMORIS cohort. J Am Heart Assoc. 2023;12(3): e027089.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1418_CR20","first-page":"2192","volume":"12","author":"P Charalampidis","year":"2022","unstructured":"Charalampidis P, Teperikidis E, Boulmpou A, Papadopoulos CE, Potoupni V, Tsioni K, Rakitzi P, Karamitsos T, Vassilikos V. Homocysteine as a predictor of paroxysmal atrial fibrillation-related events: a scoping review of the literature. Diagnostics (Basel, Switzerland). 2022;12(9):2192.","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"1","key":"1418_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacl.2019.12.002","volume":"14","author":"B Guan","year":"2020","unstructured":"Guan B, Li X, Xue W, Tse G, Waleed KB, Liu Y, Zheng M, Wu S, Xia Y, Ding Y. Blood lipid profiles and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020;14(1):133-142.e133.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"1418_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtcvs.2021.10.037","volume":"164","author":"RS Lazzaro","year":"2022","unstructured":"Lazzaro RS, Inra ML. Commentary: nomogram to the rescue: validate and show me the money. J Thorac Cardiovasc Surg. 2022;164(1):276\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1418_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132283","volume":"411","author":"C Hu","year":"2024","unstructured":"Hu C. Nomogram: a better method for evaluating MVD risk. Int J Cardiol. 2024;411: 132283.","journal-title":"Int J Cardiol"},{"issue":"8","key":"1418_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-072632","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Xi W, Zhou J, Gao W, Wu Q. Nomogram predicting overall prognosis for invasive micropapillary carcinoma of the breast: a SEER-based population study. BMJ Open. 2023;13(8): e072632.","journal-title":"BMJ Open"},{"issue":"12","key":"1418_CR25","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.2337\/dc23-0931","volume":"46","author":"S Kwon","year":"2023","unstructured":"Kwon S, Lee SR, Choi EK, Ahn HJ, Lee SW, Jung JH, Han KD, Oh S, Lip GYH. Association between atrial fibrillation and diabetes-related complications: a nationwide cohort study. Diabetes Care. 2023;46(12):2240\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"1418_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","volume":"65","author":"MK Ali","year":"2022","unstructured":"Ali MK, Pearson-Stuttard J, Selvin E, Gregg EW. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3\u201313.","journal-title":"Diabetologia"},{"issue":"4","key":"1418_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.2021.21811","volume":"327","author":"LC Kahwati","year":"2022","unstructured":"Kahwati LC, Asher GN, Kadro ZO, Keen S, Ali R, Coker-Schwimmer E, Jonas DE. Screening for atrial fibrillation: updated evidence report and systematic review for the US preventive services task force. JAMA. 2022;327(4):368\u201383.","journal-title":"JAMA"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-025-01418-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-025-01418-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-025-01418-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:11:58Z","timestamp":1757218318000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-025-01418-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1418"],"URL":"https:\/\/doi.org\/10.1186\/s12938-025-01418-0","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval was obtained from the Ethics Committee of The People\u2019s Hospital of Guangxi Zhuang Autonomous Region (Approval no. 20230912). Written informed consent was obtained from a legally authorized representative(s) for anonymized patient information to be published in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients participating in this study all agree to publish the research results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}